○Feng Li¹, Kanako Shinguchi¹, Shigeki Chiba¹ (1. Kampo Research Lab., Pharm. Company, Kracie, Ltd.)

○Yuki Shimada¹, Takeshi Suginohara¹, Seiwa Michihara¹, Shigeki Chiba¹ (1. 1.Kampo Res. Lab., Pharm. Co., Kracie, Ltd.)

○Rieko Miki¹, Naoki Ito², Kazutoshi Nishiyama¹, Yoshinori Kobayashi² (1. Grad. Sch. Med. Sci., Kitasato Univ., 2. Sch. Pharm., Kitasato Univ.)

○Erina Ishida¹, Takumi Nagamatsu¹, Kaori Kubota¹, Nao Sasakura¹, Takuya Watanabe¹, Shutaro Katsurabayashi¹, Katsunori Iwasaki¹ (1. Fac. Pharm. Sci., Fukuoka Univ.)

Chien-Jung Huang¹, Chih-Hsin Hung¹, Yi-Shan Liu², ○Po-Chuen Shieh³ (1. Department of Chemical Engineering and Institute of Biotechnology and Chemical, I-Shou University, Kaohsiung, Taiwan, 2. Department of Dermatology, E-Da Hospital & School of Chinese Medicine for post Baccalaureate, College of Medicine, I-Shou University, Kaohsiung, Taiwan, 3. Department of Pharmacy, Tajen University, Pingtung, Taiwan)

○Mayuko Inoue¹, Megumi Furukawa¹, Ryoken Aoki¹, Nagashima Daichi^1,2, Nobuo Izumo^1,2 (1. Yokohama University of Pharmacy, 2. General Health Medical Resarch Center,Yokohama University of Pharmacy)

○Shiro Watanabe¹, Kyoka Takahashi¹, Yukihiro Furusawa², Yoshiaki Tabuchi³ (1. Inst. Nat. Med., Univ. Toyama, 2. Dept. Pharm. Eng., Toyama. Pref. Univ., 3. Life Sci. Res. Ctr., Univ. Toyama)

○XINXIN FAN¹, YU LU^2,1, SIYAN LIU^1,3, RENSHI LI¹, BOYANG YU¹ (1. China Pharmaceut. Univ., 2. Grad. Sch. Pharmaceut. Sci., Kyushu Univ., 3. Queen's University Belfast)

○Naoki Ito¹, Rieko Miki², Naoya Kawada², Masaaki Yoshida³, Yoshinori Kobayashi¹ (1. Sch. Pharm., Kitasato Univ., 2. Grad. Sch. Med., Kitasato Univ., 3. Kotaro Pharm. Co.,Ltd)